Health
Google for Startups Growth Academy Admits Nigeria’s Healthtracka, Others
By Aduragbemi Omiyale
Twenty-four startups tackling a wide range of healthcare challenges using Artificial Intelligence (AI), from early cancer detection and chronic disease management to mental health support and clinical trial optimisation have been selected for the Google for Startups Growth Academy: AI for Health Program.
These small firms were chosen across Europe, the Middle East, and Africa (EMEA) regions, including Nigeria, which has Healthtracka as a representative.
Business Post reports that for three months, the participating startups from 13 countries will undergo intensive training, mentorship, and networking opportunities.
They will benefit from workshops on best practices for AI, leadership development, responsible innovation, product design, and customer acquisition.
Additionally, Google experts from Research, Health, Verily, Fitbit, and DeepMind will offer one-on-one mentorship sessions and technical project support.
Google disclosed that the companies picked for this year’s cohort exemplify the potential of AI to address pressing healthcare challenges in Sub-Saharan Africa, advancing mental health integration, providing accessible outpatient services, and delivering affordable healthcare to underserved populations.
The World Health Organisation estimated that more than 116 million people across Africa are living with mental health conditions pre-pandemic and as things stand, there are fewer than two mental health workers for every 100,000 people.
“We are committed to supporting the growth of innovative startups, particularly those that are leveraging AI to address critical healthcare challenges.
“The Growth Academy: AI for Health program is a testament to this commitment, and we are excited to see the impact these startups will have on the future of healthcare,” the Head of Communications and Public Affairs for Google, Africa, Ms Dorothy Ooko, said.
Below are the participating startups and what they do;
Aide (United Kingdom) is a digital service that helps patients and clinicians better understand and manage chronic disease, specifically comorbidity.
AmplifAI (Saudi Arabia) combines AI-driven thermography and computer vision to create a standardised and objective assessment for diabetic foot ulcers.
Biorce (Portugal) is developing solutions to enhance clinical trials through the power of AI, having created Jarvis, a clinical AI assistant.
C the Signs (United Kingdom) is an AI cancer prediction platform that helps identify patients at risk of cancer at its earliest and most curable stages.
Callyope (France) develops speech-based remote patient monitoring solutions that help caretakers assess treatment efficacy and detect relapses in serious mental illnesses such as depression, bipolar disorder and schizophrenia.
Clear.bio (Netherlands) works to reverse diabetes type 2 by precision nutrition, providing best-in-class digital therapeutic based on real-time glucometry.
Ephion Health (Spain) develops digital biomarkers to ensure accurate disease monitoring and therapy assessment, through wearables data, clinical reports and AI for precise patient assessment.
Exakt Health (Germany) is a certified medical app for physiotherapy and evidence-based training with hyper-personalised treatment plans.
FiveLives (France) is a digital brain health platform for people aged 50+ to take control of their cognitive health, through combining clinically-validated brain health assessment and an engaging coaching program.
Healthtracka (Nigeria) is decentralising access to healthcare in Africa through remote medical diagnostics, connecting users with a seamless way to access at-home lab tests, and receive clear results and doctors consultations.
HearMe (Poland) supports employees’ mental health through anonymous and secure 1:1 sessions with mental health professionals.
Juniver (United Kingdom) delivers on-demand help for eating disorders, with AI-powered interventions for urges, evidence-based education, personalised tools, peer support and telemedicine.
Mindgram (Poland) is a platform offering a holistic solution providing employees and their relatives with psychological and self-development support around the clock.
Motherbeing (Egypt) is a digital solution dedicated to Arab women’s sexual and reproductive health. The platform connects users with doctors, experts, personalised health education and an AI-powered health assistant.
Noah Labs (Germany) develops voice-based machine learning software for the early detection of decompensated heart failure.
Nui (Germany) is an app providing family caregivers with support through an intelligent chatbot that guides them to find answers to the most pressing questions.
O7 Therapy (Egypt) bridges the treatment gap with cutting-edge tech and top-tier mental health professionals. The O7 Therapy app offers instant, anonymous support via encrypted Chat, Audio and Video Sessions.
Powerful Medical (Slovakia) revolutionises cardiovascular diagnostics with its AI-driven platform, enabling healthcare professionals across the EU and beyond to diagnose and manage 39 cardiovascular conditions.
Research Grid (United Kingdom) is an automation engine enabling faster, more successful clinical trials by engineering smart software that safely automates back office admin across the full lifecycle.
Rofim (France) specialises in developing telemedicine software. The Rofim platform is a telemedicine platform designed to connect patients with healthcare professionals, enable diagnosis and improve access to care.
SYCAI Medical (Spain) develops medical device software to prevent the appearance of cancer in the abdomen non-invasively.
Thalia Psychotherapy (Kenya) is a mental health startup focused on integrating mental health services into primary healthcare systems.
TibuHealth (Kenya) delivers affordable outpatient services via “minute clinics” in partner pharmacies in high-density neighbourhoods.
Zoie Health (South Africa) is a digital health platform focused on providing underserved, high-need populations with affordable, accessible and healthcare.
Health
Court Okays FCCPC to Regulate Consumer Protection in Healthcare
By Adedapo Adesanya
The Abuja division of the Federal High Court has delivered a landmark ruling reinforcing consumer protection in Nigeria’s healthcare sector, affirming the authority of the Federal Competition and Consumer Protection Commission (FCCPC) to investigate complaints related to medical services, including alleged negligence.
Justice Emeka Nwite, who presided over the matter, delivered the judgment on April 15 in a suit filed by Life Bridge Medical Diagnostic Centre Ltd.
The company had challenged the FCCPC’s jurisdiction, arguing that the commission could not probe medical negligence cases without first establishing a formal arrangement with the Medical and Dental Council of Nigeria (MDCN).
However, the court dismissed the claims, holding that healthcare providers operating as commercial entities fall squarely under the provisions of the Federal Competition and Consumer Protection Act (FCCPA).
Justice Nwite ruled that services rendered for value, including medical diagnostics, are subject to consumer protection oversight.
In the decisive clarification, the court drew a line between professional regulation and consumer protection. It said that while disciplinary control of medical practitioners remains the responsibility of professional bodies such as the MDCN, the FCCPC retains authority over issues of service quality, fairness, and consumer satisfaction.
The court further held that Section 105 of the FCCPA, which encourages regulatory coordination, does not limit or delay the FCCPC’s statutory powers.
According to the ruling, the absence of a formal agreement with sector regulators does not invalidate the Commission’s authority to act.
Justice Nwite also addressed concerns around patient confidentiality, ruling that ethical obligations do not override lawful investigations carried out in the public interest and in compliance with due process.
Reacting to the judgment, FCCPC executive vice chairman, Tunji Bello, described the decision as a major step toward strengthening consumer rights across all service sectors.
He emphasised that the ruling underscores the principle that consumer protection and professional regulation can coexist without conflict.
Health
Resident Doctors Suspend Proposed Indefinite Strike
By Adedapo Adesanya
The Nigerian Association of Resident Doctors (NARD) has suspended its planned indefinite strike following the federal government’s reversal of the implementation of the reviewed Professional Allowance Table (PAT) and renewed assurances on outstanding payments.
The decision was announced in a communiqué issued at the end of an emergency National Executive Council (NEC) meeting held virtually on Saturday.
NARD had earlier resolved to embark on a total and indefinite strike over the government’s suspension of the reviewed allowance structure and other unresolved welfare concerns affecting resident doctors nationwide.
However, the association said it reconsidered its position after reviewing the outcomes of high-level engagements with key government officials and health-sector stakeholders.
According to the communiqué signed by NARD President, Dr Mohammad Usman Suleiman; Secretary-General, Dr Shuaibu Ibrahim; and Publicity and Social Secretary, Dr Abdulmajid Yahya Ibrahim, the Federal Government has now reversed its earlier decision on the allowance table.
“The NEC observed that the earlier decision to halt the implementation of the reviewed Professional Allowance Table (PAT) has been reversed, with implementation expected to reflect in the April salary and beyond,” the statement read.
The association also noted the government’s renewed commitment to settling outstanding promotion and salary arrears owed to resident doctors in affected institutions.
In addition, NARD said initial approval had been secured for the 2026 Medical Residency Training Fund (MRTF), with assurances that the disbursement process would be concluded.
“The NEC observed that the Budget Office has indicated its readiness to commence the process for the payment of the outstanding nineteen months’ arrears of the Professional Allowance,” the communiqué added.
Despite the progress, the doctors expressed concern about the continued delay in paying house officers’ salaries and called for urgent action to address the issue.
Following its deliberations, the NEC demanded the sustained implementation of the reviewed allowance structure, the prompt payment of all outstanding arrears, and the expedited disbursement of the residency training fund.
It also called for the immediate commencement of the process to clear the 19-month arrears and the convening of an urgent stakeholders’ meeting to resolve delays affecting house officers’ salaries.
“In light of the above developments, the NEC resolves to suspend the proposed total, indefinite, and comprehensive strike action, with a review of progress to be undertaken at the May Ordinary General Meeting (OGM) in Kano,” the statement said.
NARD expressed appreciation to President Bola Tinubu, Vice President Kashim Shettima, and several ministers, government agencies, and stakeholders for their interventions in resolving the dispute.
Health
Over 1.5 million Nigerian Children Living With Sickle Cell Disease—Report
By Modupe Gbadeyanka
More than 1.5 million children under the age of 15 are living with sickle cell disease in Nigeria, a new international study published in The Lancet Child & Adolescent Health, one of the world’s leading medical journals, has revealed.
In the report made available to Business Post, it was disclosed that Nigeria carries the highest burden of disease globally, far exceeding other high-burden countries such as the Democratic Republic of the Congo and Ethiopia.
The findings highlight both the scale of the challenge in Nigeria and the opportunity for the country to lead Africa in tackling one of the most preventable causes of childhood illness and death.
The study shows that nearly nine million children across sub-Saharan Africa are living with sickle cell disease in 2023, including around 1.17 million infants and 2.75 million children under five, who face the highest risk of early death without treatment.
Sickle cell disease is an inherited blood disorder present at birth. With early diagnosis and access to simple, low-cost interventions such as newborn screening, penicillin prophylaxis, routine vaccinations, malaria prevention, and hydroxyurea, most complications and deaths can be prevented.
However, in Nigeria, access to these essential services remains limited. Many children are only diagnosed after severe and avoidable complications, while others are never diagnosed at all, contributing to high levels of preventable illness and early childhood deaths.
The researchers emphasise that strengthening Nigeria’s health system response will be critical. This includes expanding newborn screening programmes, improving access to essential medicines, and integrating sickle cell care into primary healthcare services.
They called for urgent and coordinated action across government, health institutions, and development partners, including expanding newborn screening programmes, improving access to essential medicines and vaccines, and embedding sickle cell care within primary healthcare services.
The researchers, led by Professor Davies Adeloye, Professor of Public Health at Teesside University, United Kingdom, and Director of the International Society of Global Health (ISoGH), also called for increased domestic investment, supported by international partnerships, as well as stronger data systems to improve surveillance and guide policy decisions.
They concluded that even modest improvements in early-life screening and treatment in high-burden countries like Nigeria could transform child survival and significantly reduce preventable deaths.
“Nigeria now stands at the centre of the global sickle cell crisis. With over 1.5 million children affected, the scale is enormous, but so is the opportunity to act. We already know what works. Newborn screening and early treatment are effective, affordable, and can be delivered through existing health systems.
“If Nigeria prioritises sickle cell disease within its national health agenda and integrates care into routine maternal and child health services, we could save hundreds of thousands of young lives and significantly reduce avoidable deaths.” Professor Adeloye noted.
It was learned that the study analysed data from 40 studies across 22 African countries to produce the most comprehensive country-level estimates of childhood sickle cell disease to date.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn
